Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 810.80 INR
Change Today +4.30 / 0.53%
Volume 22.9K
As of 7:06 AM 04/28/15 All times are local (Market data is delayed by at least 15 minutes).

merck ltd (EMER) Snapshot

Open
804.60
Previous Close
806.50
Day High
820.00
Day Low
797.00
52 Week High
04/8/15 - 1,009
52 Week Low
05/19/14 - 611.05
Market Cap
13.5B
Average Volume 10 Days
22.2K
EPS TTM
26.04
Shares Outstanding
16.6M
EX-Date
03/30/15
P/E TM
31.1x
Dividend
6.00
Dividend Yield
0.74%
Current Stock Chart for MERCK LTD (EMER)

Related News

No related news articles were found.

merck ltd (EMER) Related Businessweek News

No Related Businessweek News Found

merck ltd (EMER) Details

Merck Limited manufactures and markets pharmaceuticals, bulk drugs, fine chemicals, and pigments primarily in India. The company operates in two segments, Pharmaceuticals and Chemicals. The Pharmaceuticals segment offers multi-vitamin products, such as Evion, Neurobion, and Polybion; Concor for cardio-vascular care; Carbophage for metabolic disorders; Livogen for haematinics treatment; and immuno-stimulator products comprising Immubron and Pedimune. This segment also provides consumer health care products, such as cough and cold, health protection, and women and children health products under the Nasivion, SevenSeas Original, Maxepa, Electrobion, and Evion Cream. The Chemicals segment primarily provides active pharmaceutical ingredients, excipients, and bio-pharmaceuticals for pharma and biopharma industries; pigments for the automotive, cosmetics, plastics, printing, and security industries; and various actives for the cosmetics industry, as well as functional and pearl luster effect pigments. Merck Limited also exports its products to Asian and African countries, such as Sri Lanka, Nepal, Lebanon, Kenya, Libya, and others. The company, formerly known as E. Merck Limited, was founded in 1967 and is based in Mumbai, India. Merck Limited is a subsidiary of Merck KGaA.

1,515 Employees
Last Reported Date: 03/17/15
Founded in 1967

merck ltd (EMER) Top Compensated Officers

Chief Financial Officer, Executive Director o...
Total Annual Compensation: 10.1M
Compensation as of Fiscal Year 2014.

merck ltd (EMER) Key Developments

Merck Ltd. Announces Board Changes

Merck Ltd. has announced that Dr. Peter- Ulrich Mannheimer, non- executive director of the company, has resigned from the board of directors consequent upon change of nomination by Merck KGaA as provided in the articles of association of the company. In his place, Mr. Bradley Simpson has been nominated as a non- executive director on the board of the company.

Merck Ltd Announces Board Appointments

Merck Ltd. announced that the board of directors of the company at its meeting held on February 05, 2015, to approve the Mrs. Rani Ajit Jadhav has been appointed as an Additional Director and Independent Director for a term of five years with effect from February 05, 2015, Mr. Brijesh Kapil has been appointed as an Additional Director and Whole time Director with effect from February 05, 2015 and Mr. Ali Sleiman has been appointed as an Additional Director and Whole time Director with effect from February 05, 2015.

Merck Ltd., Annual General Meeting, Apr 08, 2015

Merck Ltd., Annual General Meeting, Apr 08, 2015., at 15:00 Indian Standard Time. Location: Sunville Banquets, 3rd Floor, Royal Room, 9. Agenda: To consider the audited financial statements of the company for the year ended December 31, 2014, together with the reports of the board of directors and auditors thereon; to consider the dividend for the year 2014; to consider the appointment and reappointment of directors; to consider the re-appointment of B S R & Co. LLP as auditor; to consider the payment of remuneration to cost auditor; and to consider the agreement or transactions or arrangement with Merck KGaA, Germany, a related party, as defined in the companies Act 2013 and the Listing Agreement for purchase, sale, import and export of products, services, technical consultancy services, intellectual property rights, royalty, IT services, reimbursement/ recovery cost or other obligations on such terms and conditions as may be mutually agreed upon between the company and Merck KGaA for an amount not exceeding INR 2,000 million in each financial year.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EMER:IN 810.80 INR +4.30

EMER Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Gilead Sciences Inc $102.52 USD -0.42
Koninklijke DSM NV €51.25 EUR -0.78
Lonza Group AG SFr.130.90 CHF +1.00
Sigma-Aldrich Corp $138.87 USD -0.035
Thermo Fisher Scientific Inc $127.17 USD -0.10
View Industry Companies
 

Industry Analysis

EMER

Industry Average

Valuation EMER Industry Range
Price/Earnings 32.2x
Price/Sales 1.6x
Price/Book 2.5x
Price/Cash Flow 24.9x
TEV/Sales 1.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MERCK LTD, please visit www.merck.co.in. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.